ArticleAntibodies (Basel, Switzerland)2024

Fcγ-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy.

Karsten Beckmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.